The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp739
SINGLE USE ENDOSCOPES: THE FUTURE IS NOW
Date
May 8, 2023
Explore related products in the following collection:
This session will highlight the current state of the art around innovation in endoscopy as it pertains to climate, the environment, and the endoscopist. Our faculty experts will highlight the current state of disposable endoscopy, personalized endoscopy, ergonomics, climate change and GI health care.
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
BACKGROUND: Idiopathic gastroparesis (IG) is an increasingly prevalent subtype of gastroparesis and causes significant morbidity and decreased quality of life…